Literature DB >> 18358713

Closing the gap: cancer in Central and Eastern Europe (CEE).

Witold Zatoński1, Joanna Didkowska.   

Abstract

UNLABELLED: The health transformation that took place after the Second World War in Europe was significantly delayed in the Central and Eastern European (CEE) countries compared to countries of Northern Europe and Great Britain. However, as death rates from cardiovascular disease have begun to fall, cancer has emerged, since the 1990s, as the most common cause of death among young and middle-aged adult women (20-64 years old) in these countries. In the coming decade it seems likely to be the leading cause of death among young and middle-aged adult men.
MATERIAL AND METHODS: Data on deaths (1959-2002) in each country have been extracted from the World Health Organisation database. Population data are from the Population Division of the Department of Economic and Social Affairs of the United Nations. Direct standardisation has been undertaken using the World Standard Population.
RESULTS: The difference in life expectancy attributable to cancer for the 20-64 years of age group is 0.68 of a year (16% of the total gap) among men and 0.35 of a year (24% of the total) among women. Trends in cancer over time differ significantly by gender, age group and time period in Eastern and Western Europe. The predicted mortality rate in CEE in 2015 equates to 201/100,000 (95% CI 199-204) for men and 106/100,000 (95% CI 104-107) for women.
CONCLUSIONS: In CEE countries, deficiency of primary prevention is a main reason of poor health consciousness (consequences of smoking, fatty diet, low physical activity) and late introduction of secondary prevention responses results in worse survival of the cancer patient; however, tertiary prevention is implemented in a similar way as in western Europe. Our analysis indicates that the greatest possibilities, but also the greatest unmet needs, lie in primary and secondary prevention.

Entities:  

Mesh:

Year:  2008        PMID: 18358713     DOI: 10.1016/j.ejca.2008.02.014

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Central and Eastern European experience with sunitinib in metastatic renal cell carcinoma: a sub-analysis of the global expanded-access trial.

Authors:  Eduard Vrdoljak; Lajos Géczi; Jozef Mardiak; Tudor-Eliade Ciuleanu; Sophie Leyman; Ke Zhang; Peter Sajben; Laszlo Torday
Journal:  Pathol Oncol Res       Date:  2015-01-04       Impact factor: 3.201

2.  Evaluation of Testicular Self Examination and Testicular Partner Examination in Medical versus Non-Medical Students.

Authors:  Stefan Vallo; Jennifer Kloft; Jon Jones; Patricia John; Wael Khoder; Walid Mahmud; Jens Mani
Journal:  Curr Urol       Date:  2020-06-23

3.  Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.

Authors:  Ondrej Majek; Jan Danes; Miroslava Skovajsova; Helena Bartonkova; Lucie Buresova; Daniel Klimes; Petr Brabec; Pavel Kozeny; Ladislav Dusek
Journal:  BMC Public Health       Date:  2011-05-10       Impact factor: 3.295

4.  Assessing awareness of colorectal cancer symptoms: measure development and results from a population survey in the UK.

Authors:  Emily Power; Alice Simon; Dorota Juszczyk; Sara Hiom; Jane Wardle
Journal:  BMC Cancer       Date:  2011-08-23       Impact factor: 4.430

5.  Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

Authors:  Iva Kirac; Mario Sekerija; Iva Simunović; Lina Zgaga; Danko Velimir Vrdoljak; Dujo Kovacević; Tomislav Kulis; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

6.  Cancer Control in Central and Eastern Europe.

Authors:  Carlo La Vecchia; Pierfranco Conte
Journal:  Oncologist       Date:  2016-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.